New Zealanders for Health Research is the nation’s only dedicated public education and advocacy alliance committed to making health research a higher priority in New Zealand.
Our members span industry, patient advocacy groups, charities and research institutions. Together, our diverse alliance represents the interests of a broad community all working together to promote health and prosperity for New Zealanders.
Investment in health research is of vital importance. Not only does it improve the health and quality of people’s lives now and in the future, it also supports New Zealand’s economy through the emergence of new businesses and knowledge-based jobs for kiwis. Our voice promotes health and prosperity for New Zealand and New Zealanders.
Health research advocacy organisation New Zealanders for Health Research (NZHR) has come out in support of a Ministry for Primary Industries (MPI) proposal to add folic acid to flour to reduce the number of babies born with spina bifida and other neural tube defects. “The incidence of neural tube defects in live births which could…Read More
The government’s latest Research Science and Innovation (RSI) strategy lacks ambition and will do little, if anything, to promote increased investment in health and medical research, according to health research advocate New Zealanders for Health Research (NZHR). Consultation on the RSI strategy has recently concluded and NZHR has told MBIE that basing the strategy on…Read More
Introduction New Zealanders for Health Research (NZHR) was established in November 2015 to bring about increased investment in health research from government, industry and philanthropy. We have a commitment to ensuring that the results of health research are translated into policy and practice. As part of our aim to bring about a society which is…Read More
Introduction New Zealanders for Health Research (NZHR) was established in November 2015 to bring about increased investment in health research from government, industry and philanthropy. NZHR’s submission is that • The government’s aspirational ten year 2% R&D investment target is too low, that the 15% R&D tax incentive is insufficient, and that the strategy should…Read More